Fig. 3From: Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivationKaplan Meier survival curve of biochemical free survival rates by risk categories as a function of nadir PSA (nPSA), T-stage, and Gleason's score (GS)Back to article page